These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16364247)

  • 1. Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
    Naba H; Kakinuma C; Ohnishi S; Ogihara T
    Biochem Biophys Res Commun; 2006 Feb; 340(1):215-20. PubMed ID: 16364247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions.
    Naba H; Kuwayama C; Kakinuma C; Ohnishi S; Ogihara T
    Drug Metab Pharmacokinet; 2004 Oct; 19(5):339-51. PubMed ID: 15548845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate.
    Watanabe K; Oda S; Matsubara A; Akai S; Yokoi T
    Toxicol Lett; 2019 Jun; 307():49-58. PubMed ID: 30853469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights Into Statin Intolerance.
    Kopecky S; Baum S; Foody JM; Koren M; McKenney J; Sperling L; Wong ND;
    Clin Cardiol; 2015 Sep; 38(9):520-6. PubMed ID: 26337173
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin.
    Matsubara A; Oda S; Akai S; Tsuneyama K; Yokoi T
    Toxicol Lett; 2018 Jul; 291():184-193. PubMed ID: 29679711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast.
    Ohta M; Kawano H; Notsu T; Naba H; Imada K
    Biochem Biophys Res Commun; 2012 Jul; 424(2):301-7. PubMed ID: 22749998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statin therapy and muscle disorders].
    Abel T; Fehér J
    Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR).
    Takada Y; Tachizawa H; Kurihara H; Takayanagi M; Sasamoto T; Akashi M; Aiso M; Takamori Y; Sano N; Takikawa H
    J Hepatobiliary Pancreat Surg; 2004; 11(2):125-8. PubMed ID: 15127276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma.
    Nishio R; Shinke T; Otake H; Nakagawa M; Nagoshi R; Inoue T; Kozuki A; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Shite J; Hirata K
    Atherosclerosis; 2014 May; 234(1):114-9. PubMed ID: 24637411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
    Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; Vyas KP; Kari PH; MacDonald JS
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1225-35. PubMed ID: 1904494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
    Graham DJ; Staffa JA; Shatin D; Andrade SE; Schech SD; La Grenade L; Gurwitz JH; Chan KA; Goodman MJ; Platt R
    JAMA; 2004 Dec; 292(21):2585-90. PubMed ID: 15572716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
    Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
    Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH
    J Am Coll Cardiol; 2007 Jul; 50(5):409-18. PubMed ID: 17662392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.
    Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Marti A; Martínez JA; Moreno-Aliaga MJ
    J Nutr Biochem; 2009 Sep; 20(9):705-14. PubMed ID: 18829285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.
    Biggs MJ; Bonser RS; Cram R
    J Heart Lung Transplant; 2006 Mar; 25(3):356-7. PubMed ID: 16507432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.